Cell Therapy at the Limits

 

The Royal College of Physicians, London
 
Monday, 27 June - Tuesday, 28 June 2022

Gilead Sciences Europe Ltd/Kite

This educational event has been funded by Gilead Sciences Europe Ltd/Kite who have had no involvement in the design, development or delivery of the content.

Bristol Myers Squibb

BMS has supported this international meeting through financial sponsorship and has had no control or input into the education content of this activity, nor the logistics elements, i.e. travel, accommodation, catering, venue selection or any other aspect of the meeting.

Janssen Pharmaceutical Companies of Johnson & Johnson

Janssen Pharmaceutical Companies of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time with a focus on developing medicines in oncology, immunology, neuroscience, infectious diseases, cardiovascular and metabolic diseases. Driven by our commitment to patients, we aim to develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency. 

Learn more at www.janssen.com/uk . Follow us at www.twitter.com/JanssenUK. Janssen-Cilag Limited is one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Job number: CP-295208 Date of preparation: February 2022

Register now 

If you require any assistance, please contact us